New York, NY -- (SBWIRE) -- 06/04/2019 -- A recent market study on the Non-alcoholic Steatohepatitis (NASH) Diagnostics market applies both primary and secondary research techniques to identify new opportunities for development for the Non-alcoholic Steatohepatitis (NASH) Diagnostics market for the forecast period, 2018 -2023. The research further screens and analyses data on the market share, growth rate and size to enable stakeholders, product owners and field marketing executives identify the low-hanging fruits and reap a significant return on their investment. Importantly, the data on the current business environment of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market proves a boon for companies trying to identify next leg for growth.

The global epidemic of type 2 diabetes and rising obesity are leading to the growing prevalence of non-alcoholic steatohepatitis (NASH), especially in developed nations. According to the NASH Education Program, NASH affects around 12% of the world's adult population. More than 80% of patients with NASH are obese, 44% have type 2 diabetes, and 72% have abnormal blood lipids (triglycerides and cholesterol). The increasing prevalence of these ailments is expected to drive the demand for NASH diagnostics over the 2018-2023 period.

This report focuses on the global top players which are:: GENFIT SA, Echosens, SuperSonic Imagine, BioPredictive, One Way Liver, S.L. (OWL), VLVbio AB, Quest Diagnostics Incorporated , Prometheus Laboratories Inc., Siemens Healthcare GmbH., Exalenz Bioscience Ltd.

Request for sample report @ https://www.marketexpertz.com/sample-enquiry-form/43425

Programs and initiatives to increase awareness are anticipated to bolster market growth over the forecast period. In 2016, The NASH Education Program was established with the objective of spreading awareness among medical practitioners, patients identified with NASH, and individuals at high risk of developing it. On the other hand, rising investments for the development of accurate, reliable, and readily available diagnostic tests for NASH is expected to drive the market over the forecast period.

Diagnostic techniques segment insights:
Liver biopsy is one of the broadly accepted diagnostic techniques for NASH detection since it provides accurate results. Liver biopsy is preferred by medical practitioners owing to its ability to determine the degree of steatosis and inflammation accurately. However, the invasive liver biopsy procedure has several disadvantages, such as pain, bleeding, and the possibility of injuring other organs. Thus, the adoption of non-invasive imaging techniques and biomarkers is anticipated to increase significantly. As a result, the market size of the liver biopsy technique is expected to grow at a slower rate than biomarkers, in developed regions like North America and Europe.

Regional insights:
North America held the largest share of the NASH diagnostics market. The growing prevalence of obesity and type 2 diabetes is leading to an increasing number of patients suffering from NASH in the United States (U.S.) and Canada. NASH has been reported to be the second-most common cause for liver transplantations in the U.S. By 2020, it is expected to surpass hepatitis C as the leading cause for liver transplants. Asia-Pacific is expected to be the fastest growing market owing to increasing awareness among patients and improving healthcare infrastructure. However, the high cost of NASH diagnosis through liver biopsy is restraining the growth of the market in developing regions like Latin America and Asia-Pacific.

Purchase complete report @ https://www.marketexpertz.com/checkout-form/43425

How geography and sales fit together
The study works as a boon for all business owners trying to identify the exact size of the target audience in a specific geographic location. Non-alcoholic Steatohepatitis (NASH) Diagnostics enables entrepreneurs to determine the regional market for their business expansion. The study answers the questions below:
- Where do the requirements come from?
- Where do non-potential customers reside?
- What is the buying behaviour of the customers dwelling in a particular area?
- What is the spending power of the customers in a specific region?

The specialist consulting approach adopted to study the Non-alcoholic Steatohepatitis (NASH) Diagnostics market by size, share. and growth form an important part of this market intelligence report. Expertise research specialist not only weight upon the company profiles of the major vendors but also significant aspects such as import and export status, supply chain management, demand and supply and distribution channel. Vital statistics on product positioning, consumption volume, a dramatic shift in consumer preferences, spending power and other are explained through resources including charts, graphs, and infographics.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:
- United States
- Europe
- China
- Japan
- Southeast Asia
- India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

In this study, the years considered to estimate the market size of Conveyor Ovens are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2023

Make an inquiry @ https://www.marketexpertz.com/make-enquiry-form/43425

Most important Topics covered in this report are:
1. Market Trends & Issues
2. Growth Drivers & Enablers
3. Growth Inhibitors
4. Opportunities and Challenges
5. Recent Industry Activity
6. Product Innovations & Trends
7. Coverage of Major & Niche Players
8. Comprehensive Geographic Coverage
9. Extensive Product Coverage

The research provides answers to the following key questions:
- What will be the size of the market and the growth rate for the forecast period? 2018 - 2023?
- Which key driving forces will keep create more opportunities for the Non-alcoholic Steatohepatitis (NASH) Diagnostics market in years to come?
- Which are the most prominent players operating in the Non-alcoholic Steatohepatitis (NASH) Diagnostics market? What have been their winning strategies so far?
- Which trends from the yesteryears or the future are likely to shape the progress of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market across different regions?
- What are the threats and challenges that can act like a barrier and restrict the development of the Non-alcoholic Steatohepatitis (NASH) Diagnostics market?
- What are the future opportunities for prominent market players?

Browse complete report description @ https://www.marketexpertz.com/industry-overview/non-alcoholic-steatohepatitis-nash-diagnostics-market

Key points from table of content:
Chapter 1. Executive summary

1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary

Chapter 2. Global non-alcoholic steatohepatitis (NASH) diagnostics market - overview
2.1. Global market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), geography-wise market revenue (USD Mn), and market attractiveness analysis
2.2. Global market drivers
2.3. Global market trends
2.4. Global market challenges
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Market segmentation based on diagnostic technique - (imaging [magnetic resonance imaging {MRI}, ultrasonography, and computed tomography {CT}], liver biopsy, and biomarkers [serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers, and others]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations

Chapter 3. North America NASH diagnostics market
3.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
3.2. Market segmentation based on diagnostic technique - (imaging [magnetic resonance imaging {MRI}, ultrasonography, and computed tomography {CT}], liver biopsy, and biomarkers [serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers, and others]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations

Continued….

About MarketExpertz
Planning to invest in market intelligence products or offerings on the web? Then marketexpertz has just the thing for you - reports from over 500 prominent publishers and updates on our collection daily to empower companies and individuals catch-up with the vital insights on industries operating across different geography, trends, share, size and growth rate. There's more to what we offer to our customers. With marketexpertz you have the choice to tap into the specialized services without any additional charges.

Contact Us:
John Watson
Head of Business Development
Market Expertz | Web: www.marketexpertz.com
Direct Line: +1-800-819-3052
E-mail: sales@marketexpertz.com
News: www.marketexpertz.com/market-news